Investors sentiment increased to 1.22 in Q2 2019. Its up 0.36, from 0.86 in 2019Q1. It is positive, as 25 investors sold HOLX shares while 123 reduced holdings. 61 funds opened positions while 119 raised stakes. 249.45 million shares or 1.69% less from 253.74 million shares in 2019Q1 were reported. Earnest Prns Limited, a Georgia-based fund reported 166,360 shares. Amalgamated Commercial Bank owns 35,902 shares. Wells Fargo And Mn reported 923,379 shares. Plante Moran Advsr Ltd Com owns 600 shares for 0.01% of their portfolio. The Ohio-based Pub Employees Retirement System Of Ohio has invested 0.02% in Hologic, Inc. (NASDAQ:HOLX). Stevens Capital LP has invested 0.06% in Hologic, Inc. (NASDAQ:HOLX). Churchill Mgmt has 0.12% invested in Hologic, Inc. (NASDAQ:HOLX) for 89,616 shares. Signaturefd Limited Liability Co invested in 0% or 331 shares. Davy Asset Mgmt holds 0.74% or 47,826 shares. Synovus Fin Corporation stated it has 0% in Hologic, Inc. (NASDAQ:HOLX). Whittier Of Nevada Incorporated owns 1,325 shares or 0% of their US portfolio. Moreover, Tower Research Cap (Trc) has 0% invested in Hologic, Inc. (NASDAQ:HOLX). State Street invested 0.04% in Hologic, Inc. (NASDAQ:HOLX). Gradient Limited Liability Co invested in 104 shares. Ftb Advsrs reported 312 shares.
Parsec Financial Management Inc decreased its stake in Hologic (HOLX) by 77.72% based on its latest 2019Q2 regulatory filing with the SEC. Parsec Financial Management Inc sold 85,792 shares as the company’s stock rose 11.39% . The institutional investor held 24,599 shares of the health care company at the end of 2019Q2, valued at $1.18M, down from 110,391 at the end of the previous reported quarter. Parsec Financial Management Inc who had been investing in Hologic for a number of months, seems to be less bullish one the $13.98B market cap company. The stock increased 0.87% or $0.45 during the last trading session, reaching $52.14. About 2.07 million shares traded. Hologic, Inc. (NASDAQ:HOLX) has risen 19.41% since December 4, 2018 and is uptrending. It has outperformed by 19.41% the S&P500.
Analysts await Hologic, Inc. (NASDAQ:HOLX) to report earnings on January, 29. They expect $0.61 earnings per share, up 5.17 % or $0.03 from last year’s $0.58 per share. HOLX’s profit will be $163.57 million for 21.37 P/E if the $0.61 EPS becomes a reality. After $0.65 actual earnings per share reported by Hologic, Inc. for the previous quarter, Wall Street now forecasts -6.15 % negative EPS growth.
More notable recent Hologic, Inc. (NASDAQ:HOLX) news were published by: Nasdaq.com which released: “Thursday Sector Laggards: Utilities, Healthcare – Nasdaq” on November 07, 2019, also Finance.Yahoo.com with their article: “Hedge Funds Love Hologic, Inc. (HOLX) Way More Than These 3 Stocks – Yahoo Finance” published on December 03, 2019, Seekingalpha.com published: “Hologic FQ4 top line up 6%; earnings down 21% – Seeking Alpha” on November 06, 2019. More interesting news about Hologic, Inc. (NASDAQ:HOLX) were released by: Nasdaq.com and their article: “Hologic (HOLX) Set to Divest Medical Aesthetics Business – Nasdaq” published on November 22, 2019 as well as Businesswire.com‘s news article titled: “Hologic Announces FDA Approval of 3DQuorumâ„¢ Imaging Technology, Powered by Genius AIâ„¢ – Business Wire” with publication date: November 12, 2019.
Hologic, Inc. (NASDAQ:HOLX) Ratings Coverage
Among 5 analysts covering Hologic (NASDAQ:HOLX), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Hologic has $59 highest and $4800 lowest target. $53.60’s average target is 2.80% above currents $52.14 stock price. Hologic had 11 analyst reports since June 21, 2019 according to SRatingsIntel. The stock of Hologic, Inc. (NASDAQ:HOLX) earned “Buy” rating by Needham on Monday, November 4. The stock has “Buy” rating by Needham on Friday, June 21. The firm has “Buy” rating by BTIG Research given on Monday, October 14. Piper Jaffray maintained Hologic, Inc. (NASDAQ:HOLX) rating on Wednesday, October 16. Piper Jaffray has “Buy” rating and $59 target. The firm has “Hold” rating by Canaccord Genuity given on Monday, November 11. The firm earned “Hold” rating on Monday, August 5 by Stifel Nicolaus.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.